As per existent norms, insurers are permitted to enter Forward Rate Agreements (FRAs), Interest Rate Swaps (IRS) and Exchange Traded Interest Rate Futures (IRF) with a maximum tenure of one year.
However, as per the final guidelines insurers would be able participate in interest rate derivatives over one year. However, there is no upper cap for maturities of such instruments.
Participation in interest rate derivatives would help such companies to protect their return due to fluctuation in the interest rates and protect financial health.
Some of the products of insurance companies provide guranteed return. However, due to fluctuation in the interest rates, returns can come down. This can put pressure on the finances companies.
Also Read
As per the guidelines, the objective of any use of the listed derivatives is that they must be used for hedging purposes only to reduce the interest rate risk.
"Companies enter into these agreements to hedge the interest rate risk on investments and the forecast transactions. Hedging interest rate risk of investment in fixed income securities would cover fixed income derivative positions that are designed to offset the potential losses from existing fixed income investments of them," it said.
This would exclude ULIP funds in case of life insurers and the shareholders funds taken together, it added.
The mark-to market gain or loss arising out of the effective hedge would be borne by the respective fund only.
Exposure limits pertaining to single issuer, group and industry will be applicable for the exposure through FRA and IRS contracts, it said.
"The guidelines are fairly comprehensive and there is a fair amount of checks and balances so that insurance companies do run into the risk of overexposures of such instruments," Batra said.